Qiwei Jiang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
Papers in
-
- Cancer-related molecular mechanisms research 9
- Cancer, Lipids, and Metabolism 3
-
- PI3K/AKT/mTOR signaling in cancer 4
- RNA Interference and Gene Delivery 3
- Co-authors
- Zhi Shi (25 shared papers)Jianping Guo (17 shared papers)Meng-Ning Wei (17 shared papers)Wenji Zhang (13 shared papers)Jian-Ge Qiu (11 shared papers)Xueji Wu (11 shared papers)Zicheng Sun (5 shared papers)Wu-Ming Qin (9 shared papers)
- Journals
- International Journal of Biological Sciences (4 papers)Frontiers in Oncology (4 papers)Oncotarget (4 papers)Frontiers in Pharmacology (2 papers)Advanced Science (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Qiwei Jiang
59 papers receiving 2.2k citations
Qiwei Jiang's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 330
- Molecular Biology 1.1k
- Oncology 383
- Biomaterials 162
- Complementary and alternative medicine 85
Countries citing papers authored by Qiwei Jiang
This map shows the geographic impact of Qiwei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiwei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiwei Jiang more than expected).
Fields of papers citing papers by Qiwei Jiang
This network shows the impact of papers produced by Qiwei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiwei Jiang. The network helps show where Qiwei Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Qiwei Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 159 | |
| 2 | 2015 | 112 | |
| 3 | High-fat diet promotes liver tumorigenesis via palmitoylation and activation of AKT Hit paper breakdown → | 2024 | 111 |
| 4 | 2020 | 103 | |
| 5 | 2014 | 102 | |
| 6 | Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo. | 2015 | 79 |
| 7 | 2014 | 76 | |
| 8 | 2011 | 69 | |
| 9 | 2021 | 67 | |
| 10 | 2015 | 63 | |
| 11 | 2015 | 61 | |
| 12 | 2015 | 61 | |
| 13 | 2015 | 57 | |
| 14 | 2019 | 55 | |
| 15 | 2019 | 54 | |
| 16 | 2021 | 54 | |
| 17 | 2022 | 54 | |
| 18 | Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editing. | 2016 | 47 |
| 19 | 2022 | 45 | |
| 20 | 2019 | 44 |
About Qiwei Jiang
Qiwei Jiang is a scholar working on Cancer Research, Molecular Biology, Oncology, Nutrition and Dietetics and Immunology, having authored 59 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), Cancer-related Molecular Pathways (5 papers), Cancer Mechanisms and Therapy (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), RNA Interference and Gene Delivery (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Trace Elements in Health (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (330 citations), Molecular Biology (1.1k citations), Oncology (383 citations), Biomaterials (162 citations) and Complementary and alternative medicine (85 citations). Qiwei Jiang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhi Shi, Jianping Guo, Meng-Ning Wei, Wenji Zhang, Jian-Ge Qiu, Xueji Wu, Zicheng Sun, Wu-Ming Qin, Xiao-Long Mei and Wenyi Wei. Their work appears in journals such as International Journal of Biological Sciences, Frontiers in Oncology, Oncotarget, Frontiers in Pharmacology and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.